M Botta Selected Research

M Botta Research Topics

10	Neoplasms (Cancer) 01/2011 - 06/2000
3	Malignant Mesothelioma 08/2013 - 02/2001
2	COVID-19 09/2022 - 01/2022
2	Mesothelioma 02/2012 - 02/2001
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011 - 02/2007
2	Philadelphia Chromosome 01/2011 - 02/2007
2	Thyroid Neoplasms (Thyroid Cancer) 06/2008 - 11/2007
2	Pleural Effusion (Pleural Effusions) 05/2002 - 02/2001
1	Hypoxia (Hypoxemia) 09/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Insulin Resistance 11/2018
1	Brain Diseases (Brain Disorder) 01/2011
1	Acute Pain 01/2011
1	Arthritis (Polyarthritis) 01/2011
1	Infections 01/2011
1	Type 2 Diabetes Mellitus (MODY) 01/2010
1	Heart Diseases (Heart Disease) 01/2010
1	Anaplastic Thyroid Carcinoma 06/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2008
1	Leukemia 01/2008
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Hypertension (High Blood Pressure) 07/2002
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2002
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2002
1	Acute Kidney Injury (Acute Renal Failure) 05/2002
1	Tumor Lysis Syndrome 05/2002
1	Dyspnea (Shortness of Breath) 05/2002
1	Paramyxoviridae Infections (Parainfluenza) 12/2001
1	Hypothyroidism 06/2001
1	Cardiotoxicity 02/2001
1	Fever (Fevers) 02/2001
1	Pleurisy (Pleuritis) 02/2001
1	Breast Neoplasms (Breast Cancer) 10/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2000
1	Vomiting 06/2000
1	Diarrhea 06/2000
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2000
1	Gastritis 06/2000

2	Pemetrexed (MTA)FDA Link 08/2013 - 02/2008
2	Carboplatin (JM8)FDA LinkGeneric 08/2013 - 02/2008
2	pyrimidineIBA 02/2012 - 11/2007
2	Phosphotransferases (Kinase)IBA 01/2011 - 02/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2011 - 01/2008
2	Fluorouracil (Carac)FDA LinkGeneric 10/2000 - 06/2000
1	Oxygen (Dioxygen)IBA 09/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	AdipokinesIBA 11/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013
1	Bevacizumab (Avastin)FDA Link 08/2013
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011
1	Viral ProteinsIBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Potassium Sparing DiureticsIBA 01/2010
1	Liposomes (Liposome)IBA 06/2008
1	Unilamellar LiposomesIBA 06/2008
1	Tyrosine Kinase InhibitorsIBA 01/2008
1	EnzymesIBA 02/2007
1	bcr-abl Fusion ProteinsIBA 02/2007
1	tyrosine receptor (receptor, tyrosine)IBA 02/2007
1	src-Family KinasesIBA 01/2007
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2002
1	SteroidsIBA 05/2002
1	4(3H)-pyrimidinoneIBA 12/2001
1	UracilIBA 12/2001
1	UridineIBA 12/2001
1	Protons (Proton)IBA 06/2001
1	Adenosine Triphosphate (ATP)IBA 06/2001
1	Interleukin-2 (IL2)IBA 02/2001
1	Cytotoxins (Cytolysins)IBA 02/2001
1	AnthracyclinesIBA 10/2000
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2000
1	AcidsIBA 07/2000
1	Contrast MediaIBA 07/2000
1	Gemcitabine FDA Link 06/2000
1	Antineoplastic Agents (Antineoplastics)IBA 06/2000

7	Therapeutics 09/2022 - 02/2001
4	Drug Therapy (Chemotherapy) 02/2008 - 06/2000
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2022
1	Tracheostomy 01/2022
1	Pain Management 01/2010
1	Immunotherapy 02/2001
1	Conservative Treatment 02/2001
1	Intra-Arterial Infusions 06/2000